Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial

SIMPLE SUMMARY: We compared the pre-planned histopathological responses, such as tumor regression grade (TRG), modified TRG, and dangerous halo (DH) of resected liver metastases, in patients who received modified FOLFOX6 plus bevacizumab and modified FOLFOX6 plus cetuximab for liver-limited colorect...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Takao, Ishida, Kazuyuki, Emi, Yasunori, Sakamoto, Michiie, Imura, Johji, Aishima, Shinichi, Muro, Kei, Uetake, Hiroyuki, Oki, Eiji, Katayose, Yu, Yoshida, Kazuhiro, Unno, Michiaki, Hyodo, Ichinosuke, Tomita, Naohiro, Sugihara, Kenichi, Maehara, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496839/
https://www.ncbi.nlm.nih.gov/pubmed/36139557
http://dx.doi.org/10.3390/cancers14184392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496839/
https://www.ncbi.nlm.nih.gov/pubmed/36139557
http://dx.doi.org/10.3390/cancers14184392

Ejemplares similares